BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33084863)

  • 21. Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661/RAB3D.
    Lin X; Zhong L; Wang N; Chu X; Liu B
    Cell Cycle; 2022 Sep; 21(17):1811-1826. PubMed ID: 35549813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non-small cell lung cancer by targeting miR-1182/TFAM axis.
    Wang W; Sun H; Ma X; Zhu T; Zhang H
    Thorac Cancer; 2022 Oct; 13(20):2867-2878. PubMed ID: 36056804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
    Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
    Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. hsa_circ_0000518 Facilitates Non-Small-Cell Lung Cancer Progression via Moderating miR-330-3p and Positively Regulating SLC1A5.
    Lv H; Shi Z; Sui A; Zhang Y; Peng L; Wang M; Zhang F
    J Immunol Res; 2022; 2022():4996980. PubMed ID: 35874898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Sponge Interaction Between Circular RNA and microRNA Serves as a Fast-Evolving Mechanism That Suppresses Non-small Cell Lung Cancer (NSCLC) in Humans.
    Wu L; Cao M; Pu X; Liu B; Wang J
    J Mol Evol; 2022 Oct; 90(5):362-374. PubMed ID: 36036266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA_0120376 regulates microRNA-148b-3 and centrosomal protein 55 to promote non-small cell lung cancer development.
    Du T; Yi S; Wang Y; Zhao Q; Ma P; Jiang W
    Bioengineered; 2022 May; 13(5):11844-11855. PubMed ID: 35549631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis.
    Yang B; Zhang B; Qi Q; Wang C
    BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
    Li Y; Ma Z; Luo M; Liang R
    Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA (circ)_0129047 upregulates bone morphogenetic protein receptor type 2 expression to inhibit lung adenocarcinoma progression by sponging microRNA (miR)-1206.
    Xue X; Chen Y
    Bioengineered; 2022 May; 13(5):12067-12087. PubMed ID: 35570745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis.
    Cai Y; Dong Z; Wang J
    World J Surg Oncol; 2022 Oct; 20(1):329. PubMed ID: 36192755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ_0060967 facilitates proliferation, migration, and invasion of non-small-cell lung cancer cells by sponging miR-660-3p/UBN2.
    Zhu Z; Zhang K; Lou M; Tong J; Wu Q; Lu J; Yuan K
    Mol Cell Biochem; 2023 May; 478(5):1129-1140. PubMed ID: 36229758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis.
    Bai C; Wang C; Hua J; Zhao N; Li T; Li W; Niu W; Zhong B; Yang S; Chen C; Zhao G; Qiu L; Jiang Z; Li L; Li Y; Wang H
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167234. PubMed ID: 38750769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circ-N4BP2L2 enhances mitochondrial function in non-small cell lung cancer cells through regulating the miR-135a-5p/ARL5B axis.
    Shi H; Ji Y; Zhang Y; Wang Y; Li W
    Environ Toxicol; 2023 Mar; 38(4):883-898. PubMed ID: 36637163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA hsa_circ_0023404 promotes proliferation, migration and invasion in non-small cell lung cancer by regulating miR-217/ZEB1 axis.
    Liu C; Zhang Z; Qi D
    Onco Targets Ther; 2019; 12():6181-6189. PubMed ID: 31496723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ_0007841 participates in progression of nonsmall cell lung cancer via miR-199a-5p/SphK2 axis.
    Long F; Li Z; Wei Z; Xie Y
    Anticancer Drugs; 2022 Nov; 33(10):1035-1046. PubMed ID: 36066393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircRNA hsa_circ_0000043 acts as a miR-4492 sponge to promote lung cancer progression via BDNF and STAT3 expression regulation in anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide-transformed 16HBE cells.
    Liu J; Xie J; Xu E; Xu B; Zhou J; Zhou J; Yang Q
    Toxicol Sci; 2023 Aug; 195(1):87-102. PubMed ID: 37326964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma.
    Fan J; Xia X; Fan Z
    J Clin Lab Anal; 2022 Sep; 36(9):e24591. PubMed ID: 35908770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ_0102231 inactivates the PI3K/AKT signaling pathway by regulating the miR-635/NOVA2 pathway to promote the progression of non-small cell lung cancer.
    Liu J; Yu Q; Yang X
    Thorac Cancer; 2023 Dec; 14(35):3453-3464. PubMed ID: 37864285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of hsa_circ_0000018/let-7f-5p/ FAM96A axis in lung adenocarcinoma progression.
    Li Q; Zhao M; Hu DD; Qin JJ; He W
    Cancer Biomark; 2024; 39(3):187-195. PubMed ID: 38043005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.